Treehill Emmetropes is the joint venture between Treehill Partners and Emmetropes that advises clients exclusively in the ophthalmology sector on M&A, capital raising as well as BD&L transactions.
A seamless team of seasoned industry experts with deep sector knowhow coupled with top tier banking expertise providing our clients with bespoke transactional services across geographies.
Our team members have a combined >100 years of ophthalmology experience and have completed transactions above $150 billion in cumulative value.
We meet the needs of our clients at every stage of development, from identifying seed funding to capital raising to sale or acquisition of a business.
Clients benefit from our unmatched combined ophthalmology and transaction experience:
Across all domains of the ophthalmology market including bio/pharmaceuticals, medical devices, instrumentation and clinics.
Informed with up-to-date perspectives driven by participation at all key sector events and continuous collaboration with sector experts and corporations.
Robust approach to transaction planning and execution:
Optimally position investment highlights
Identify and resolve transaction hurdles
Drive competitive transaction dynamics to maximize efficiency and value
Understand implications of strategic choices.
Our clients are large and small companies from across the globe, as well as investors active in the area.
About our Partner
Treehill Partners is an insight-driven healthcare transaction advisory firm bringing decades of top tier investment banking, consulting and senior management experience into focus for their clients. Treehill’s deep scientific and clinical expertise coupled with its end-to-end approach to each mandate ensures it prepares and positions its clients optimally to transact or transition, identify the right partner and the right sources of capital to maximize value creation for management and shareholders alike.